Skip to content
DataLookout
Start free
Menu

BenidipineTRNCT06808321

Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Results posted: Nov 4, 2026 Show 8 more changesShow less
    • Primary endpoint(s) modified
    • Trial status changed: Enrolling by Invitation → Completed
    • Final enrollment: 1659 participants (planned 800)
    • Study completion date changed from estimate of Jun 1, 2026 to Jan 1, 2026
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints expanded, about 8 words
    • Study description expanded, about 137 words
    • Study site revised
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Primary completion date: Nov 1, 2025 to Jan 1, 2026
    • Start date changed from estimate of Jun 1, 2025 to Mar 1, 2025
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change From Baseline in Systolic Blood Pressure at Month 3
Timeframe: Baseline and Month 3
Change From Baseline in Diastolic Blood Pressure at Month 3
Timeframe: Baseline and Month 3
Change From Baseline in Seattle Angina Questionnaire Score at Month 3
Timeframe: Baseline and Month 3

Secondary (1)

Treatment Persistence and Patient Compliance at Month 3

Arms and interventions

Drugs: Benidipine Hydrochloride

Sites

1 site in 1 country

  • Ege UniversityIzmir, Bornova, Turkey (Türkiye)